Svas Biosana Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	46	38	43	55	87	-
Market Cap Growth	5.57%	-11.25%	-20.87%	-37.13%	-	-
Enterprise Value	91	69	72	84	129	-
Last Close Price	8.58	6.89	7.46	9.14	14.46	-
PE Ratio	6.76	6.52	8.43	15.29	27.47	-
Forward PE	6.13	5.92	8.56	10.60	-	-
PS Ratio	0.34	0.31	0.36	0.55	1.06	-
PB Ratio	0.71	0.61	0.73	1.00	1.70	-
P/TBV Ratio	0.97	0.75	0.89	1.22	2.07	-
P/FCF Ratio	-	26.90	83.07	28.74	-	-
P/OCF Ratio	-	7.46	10.06	11.17	34.24	-
EV/Sales Ratio	0.67	0.56	0.60	0.84	1.57	-
EV/EBITDA Ratio	5.70	4.70	5.33	7.55	12.49	-
EV/EBIT Ratio	8.21	7.01	8.45	13.31	22.30	-
EV/FCF Ratio	-20.89	48.22	139.22	44.04	-	-
Debt / Equity Ratio	1.13	1.05	1.14	1.01	1.07	1.69
Debt / EBITDA Ratio	4.60	4.51	4.94	4.99	5.27	5.16
Debt / FCF Ratio	-	46.31	129.22	29.10	-	4.50
Net Debt / Equity Ratio	0.70	0.46	0.46	0.47	0.46	1.43
Net Debt / EBITDA Ratio	2.83	1.95	2.00	2.32	2.26	4.37
Net Debt / FCF Ratio	-10.36	20.06	52.27	13.55	-278.79	3.81
Asset Turnover	0.80	0.74	0.78	0.71	0.67	-
Inventory Turnover	2.88	2.64	2.86	2.58	2.35	-
Quick Ratio	1.30	1.42	1.38	1.28	1.34	0.83
Current Ratio	1.80	1.98	1.89	1.81	1.86	1.34
Return on Equity (ROE)	10.92%	9.65%	9.03%	6.77%	8.03%	-
Return on Assets (ROA)	4.08%	3.70%	3.43%	2.78%	2.96%	-
Return on Invested Capital (ROIC)	7.45%	8.10%	7.76%	6.24%	6.41%	5.34%
Return on Capital Employed (ROCE)	10.30%	9.50%	8.50%	7.10%	6.70%	8.70%
Earnings Yield	14.79%	15.33%	11.86%	6.54%	3.64%	-
FCF Yield	-9.51%	3.72%	1.20%	3.48%	-0.10%	-
Dividend Yield	2.87%	3.63%	4.02%	-	-	-
Payout Ratio	19.64%	27.24%	-	-	-	-
Total Shareholder Return	2.87%	3.63%	4.02%	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.